Wells Fargo Thinks The Street May Have Already Priced In Dr Pepper's Q2 Results
Following its analysis of Dr Pepper Snapple Group Inc. (NYSE: DPS)'s second-quarter results, Wells Fargo said it continues to think the company is managing its business well to drive top-line growth and margin expansion. Stating that the performance and multiple expansion over the past few years is justified, the firm said it sees limited reason for meaningful margin expansion, citing few additional catalysts in the longer term.
Strong Quarterly Results
Bonnie Herzog, analyst at Wells Fargo, noted that the company reported strong quarterly results, with earnings ahead of expectations. The analyst indicated that volume growth came about from strong showing by carbonated soft drinks, Schweppes and Allied Brands. Favorable macros and productivity initiatives benefited margins, according to Herzog.
Unlike The Coca-Cola Co (NYSE: KO), which saw flat global volume growth this second quarter, the analyst noted that Dr Pepper Snapple grew volumes. This, according to the firm, is an indication that the company is fairly insulated from international macro instability headwinds.
Q2 Top-Line Growth Dissected
Wells Fargo noted that the 4 percent currency neutral net sales growth was driven by favorable product and package mix, pricing and volume, while unfavorable segment mix served as drag. Carbonated soft drink volumes rose 1 percent, and non-carbonated soft drink volumes were up a steeper 2 percent, with waters giving a real thrust at 25 percent growth.
The firm also noted that operating margins expanded 80 basis points to 22.8 percent, contributing to 6 percent adjusted operating income growth.
Wells Fargo indicated that the company raised its 2016 guidance yet again, reflecting primarily the 2Q earnings beat. Given the underlying momentum in the company's business, the revised guidance remains conservative in the firm's view.
Premium Valuation Justified
The firm noted that consistent earnings growth and broad multiple expansion have helped the company's shares outperform the market and its peers over the last three years. The firm believes the performance and multiple expansion over the past few years is justified. That said, the firm sees limited scope of further meaningful expansion.
Raising Valuation Range
Wells Fargo raised its valuation range for the shares of the company to $91– $93 from $89–$91, assuming they trade at 11.6 times its 2017 EBITDA estimate and 19.1 times its 2017 earnings per share estimate.
The analysts currently have a Market-Perform rating on the stock.
At time of writing, Dr Pepper Snapple was trading at $97.98, up 1.85 percent on the day.
Do you have ideas for articles/interviews you'd like to see more of on Benzinga? Please email firstname.lastname@example.org with your best article ideas. One person will be randomly selected to win a $20 Amazon gift card!
Latest Ratings for DPS
|Feb 2017||Credit Suisse||Reinstates||Outperform|
|Jan 2017||Barclays||Initiates Coverage On||Equal-Weight|
|Jan 2017||Goldman Sachs||Upgrades||Sell||Neutral|
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.